EE03205B1 - Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks - Google Patents

Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks

Info

Publication number
EE03205B1
EE03205B1 EE9400347A EE9400347A EE03205B1 EE 03205 B1 EE03205 B1 EE 03205B1 EE 9400347 A EE9400347 A EE 9400347A EE 9400347 A EE9400347 A EE 9400347A EE 03205 B1 EE03205 B1 EE 03205B1
Authority
EE
Estonia
Prior art keywords
pct
ropivacaine
manufacture
analgesic
medicament
Prior art date
Application number
EE9400347A
Other languages
English (en)
Inventor
Torsten Eek Arne
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE03205(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE03205B1 publication Critical patent/EE03205B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Steroid Compounds (AREA)
  • Air Conditioning Control Device (AREA)
  • Electromechanical Clocks (AREA)
  • Particle Accelerators (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EE9400347A 1993-06-28 1994-11-03 Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks EE03205B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use

Publications (1)

Publication Number Publication Date
EE03205B1 true EE03205B1 (et) 1999-08-16

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400347A EE03205B1 (et) 1993-06-28 1994-11-03 Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks

Country Status (33)

Country Link
US (2) US5670524A (et)
EP (1) EP0706395B1 (et)
JP (1) JP3725541B2 (et)
CN (1) CN1074918C (et)
AT (1) ATE216237T1 (et)
BR (1) BR9406865A (et)
CA (1) CA2165446C (et)
CZ (1) CZ283300B6 (et)
DE (2) DE69430427T2 (et)
DK (1) DK0706395T3 (et)
EE (1) EE03205B1 (et)
ES (1) ES2099048T3 (et)
FI (1) FI956269A (et)
GR (1) GR970300013T1 (et)
HK (1) HK1010344A1 (et)
HU (1) HU218949B (et)
IL (1) IL110006A (et)
IS (1) IS4174A (et)
LT (1) LT3449B (et)
LV (1) LV12918B (et)
MY (1) MY119360A (et)
NO (1) NO955313L (et)
NZ (1) NZ268110A (et)
PH (1) PH31258A (et)
PL (1) PL175518B1 (et)
PT (1) PT706395E (et)
RU (1) RU2152215C1 (et)
SA (1) SA94150010B1 (et)
SE (1) SE9302218D0 (et)
SG (1) SG49078A1 (et)
SK (1) SK280111B6 (et)
TW (1) TW285640B (et)
WO (1) WO1995000148A1 (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
WO1999004771A2 (en) * 1997-07-21 1999-02-04 Darwin Discovery Limited Use of levobupivacaine
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
USRE46397E1 (en) 2007-11-07 2017-05-09 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
RU2678433C2 (ru) 2012-05-10 2019-01-29 Пейнреформ Лтд. Депо-составы гидрофобного активного ингредиента и способы их получения
SG11201407323WA (en) * 2012-05-10 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of local pain
JP6114841B2 (ja) 2013-02-28 2017-04-12 ダーミラ， インク．Ｄｅｒｍｉｒａ， Ｉｎｃ． グリコピロレート塩
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151110B1 (en) * 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
DE69430427T2 (de) 2002-11-14
DK0706395T3 (da) 2002-07-22
AU7086694A (en) 1995-01-17
DE706395T1 (de) 1997-09-04
ES2099048T3 (es) 2002-11-16
IL110006A0 (en) 1994-11-11
DE69430427D1 (de) 2002-05-23
IL110006A (en) 1999-01-26
HUT75115A (en) 1997-04-28
CZ336495A3 (en) 1996-06-12
NZ268110A (en) 1999-06-29
GR970300013T1 (en) 1997-05-31
SK280111B6 (sk) 1999-08-06
SK164695A3 (en) 1996-07-03
PT706395E (pt) 2002-09-30
CN1126435A (zh) 1996-07-10
PL312198A1 (en) 1996-04-01
US5834489A (en) 1998-11-10
LT3449B (en) 1995-10-25
LV12918B (en) 2003-03-20
IS4174A (is) 1994-12-29
CA2165446C (en) 2005-07-05
TW285640B (et) 1996-09-11
SA94150010B1 (ar) 2006-04-04
HU9503692D0 (en) 1996-02-28
HU218949B (hu) 2001-01-29
SG49078A1 (en) 1998-05-18
CA2165446A1 (en) 1995-01-05
PH31258A (en) 1998-06-18
CN1074918C (zh) 2001-11-21
EP0706395B1 (en) 2002-04-17
LTIP1958A (en) 1995-01-31
FI956269A0 (fi) 1995-12-27
RU2152215C1 (ru) 2000-07-10
ATE216237T1 (de) 2002-05-15
ES2099048T1 (es) 1997-05-16
FI956269A (fi) 1995-12-27
CZ283300B6 (cs) 1998-02-18
NO955313D0 (no) 1995-12-27
PL175518B1 (pl) 1999-01-29
JPH09500620A (ja) 1997-01-21
WO1995000148A1 (en) 1995-01-05
EP0706395A1 (en) 1996-04-17
NO955313L (no) 1995-12-27
BR9406865A (pt) 1996-03-26
MY119360A (en) 2005-05-31
JP3725541B2 (ja) 2005-12-14
SE9302218D0 (sv) 1993-06-28
AU692161B2 (en) 1998-06-04
HK1010344A1 (en) 1999-06-17
US5670524A (en) 1997-09-23

Similar Documents

Publication Publication Date Title
NO960067D0 (no) Nytt farmasöytisk preparat
MY119403A (en) Novel compounds with analgesic effect.
NZ324887A (en) Piperazine and piperidine compounds with analgesic effect
EP1428821A8 (en) Piperidin-4-yl amines with analgesic effect
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
SE9401728D0 (sv) New compounds II
EE03205B1 (et) Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks
EE9800132A (et) 1-(2-naft-2-üületüül)-4-(3-trifluorometüülfenüül)-1,2,3,6,-tetrahüdropüridiini kasutamine ravimite valmistamiseks amüotroofilise lateraalskleroosi raviks
DE69516671D1 (de) Verbindungen mit analgetischem und lokalanesthetischem effekt
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
AU6519596A (en) Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
MX9804797A (es) Nuevos compuestos con efecto analgesico.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20101103